Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES 9. Verify Nomination in Account, click on link (:: Central Depository Services (India) Limited :: )
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Customer Guest
Login | Register
Login | Register|Forgot password?
Bafna Pharmaceuticals Limited has informed the Exchange about retirement of Mr. Navin Kumar (DIN: 08778662) as an Independent Director of the Company...more...
Intimation for retirement of Mr. Navin Kumar (DIN: 08778662) as an Independent Director of the Company upon completion of his first term wit...more...
Intimation for retirement of Mr. Navin Kumar (DIN: 08778662) as an Independent Director of the Company upon completion of his first term with effect ...more...
Bafna Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication for the Audited Financial Results of the Company...more...
The company reported standalone net profit of Rs 2.75 crore for the quarter ended March 31 2026 as compared to Rs 1.31 crore in the same period last ...more...
We herewith enclose the Audited Financial Results of the Company along with the Statutory Auditor s Report for the Quarter and Year ended Ma...more...
We hereby inform you that the Board of Directors in their meeting held on May 29 2026 inter-alia considered and approved the Audited Financial Result...more...
SRJR Lifesciences LLP has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of Indi...more...
Bafna Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider...more...
As of March 2026 75.00% is owned by Indian Promoters and 25.00% by Public. Top five Promoters holding highest number of shares of Bafna Phar...more...
Significant movement in price has been observed in Bafna Pharmaceuticals Limited. The Exchange in order to ensure that investors have latest relevant...more...
We hereby submit our response to the Clarification sought by the Stock Exchange regarding the movement in the Share Price of the Company.more...
The Exchange has sought clarification from Bafna Pharmaceuticals Ltd on April 13 2026 with reference to significant movement in price in ord...more...
Bafna Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations 2018 for the Quarter...more...
Certificate under Regulation 74(5) of SEBi (DP) Regulations 2018 for the Quarter ended March 31 2026.more...
Bafna Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on March 27 2026 in which the Board of Directors has ...more...
The Board of Directors of the Company in the Meeting held on March 27 2026 has inter-alia considered and approved: (i) The appointment of M/...more...
Bafna Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regula...more...
We hereby submit our response to the clarification sought by the Stock Exchange regarding the movement in the share price of the Company.more...
BOARD MEETINGS Company Name : Majestic Research Date : 30-06-2026